HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Human epidermal growth factor receptor 2 (HER2) overexpression and amplification have been reported as predictive markers for HER2-targeted therapy in breast and gastric cancer, whereas human epidermal growth factor receptor 3 (HER3) is emerging as a potential resistance factor. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Galdy, Salvatore, Lamarca, Angela, McNamara, Mairéad G., Hubner, Richard A., Cella, Chiara A., Fazio, Nicola, Valle, Juan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Non-Thematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385197/
https://www.ncbi.nlm.nih.gov/pubmed/27981460
http://dx.doi.org/10.1007/s10555-016-9645-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385197/
https://www.ncbi.nlm.nih.gov/pubmed/27981460
http://dx.doi.org/10.1007/s10555-016-9645-x

Ejemplares similares